Search

Your search keyword '"Mantovani, Lorenzo G"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Mantovani, Lorenzo G" Remove constraint Author: "Mantovani, Lorenzo G" Publication Type Magazines Remove constraint Publication Type: Magazines
61 results on '"Mantovani, Lorenzo G"'

Search Results

1. Cost‐Effectivenessof the Early Arthritis Clinic Organizational Model

2. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE

3. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE

4. Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017

6. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE

7. Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

8. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

9. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

10. Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017

11. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

14. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry

15. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation

18. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study

19. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

20. Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

21. Major diabetes complications have an impact on total annual medical cost of type 2 diabetes

22. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016

23. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016

24. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

25. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

26. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

29. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

30. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study

31. Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISEStudy

32. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation

34. The economic burden of chronic obstructive pulmonary disease in the elderly

36. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy a retrospective cohort study in primary care

37. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

39. CAPTOPRIL IN THE MANAGEMENT OF PATIENTS AFTER ACUTE MYOCARDIAL INFARCTIONS. A COST EFFECTIVENESS ANALYSIS IN ITALY

40. Is Preventive Medical Care Worth the Cost?

41. Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

46. Subgroup Analysis of Patients with Cancer in Xalia - a Non-Interventional Study of Rivaroxaban in Routine Treatment of Deep Vein Thrombosis

47. Spinal Fusion Surgery: Epidemiologic and Economic Burden Attributable to First Intervention

48. Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference?

49. Xalia, a Non-Interventional Study Comparing Rivaroxaban with Standard Anticoagulation for Initial and Long-Term Therapy in Deep Vein Thrombosis

Catalog

Books, media, physical & digital resources